{"disease":{"id":"severe-combined-immunodeficiency","name":"severe combined immunodeficiency"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT03655223","title":"Early Check: Expanded Screening in Newborns","phase":"","overall_status":"ENROLLING_BY_INVITATION","enrollment_count":30000,"lead_sponsor_name":"RTI International","has_results":false},{"nct_id":"NCT06659588","title":"Study of Populations at Risk of Developing Chronic Hepatitis Linked to Chronic Enteric Virus Infection in Patients With Primary Immunodeficiency and Secondary Humoral Deficiency","phase":"","overall_status":"RECRUITING","enrollment_count":120,"lead_sponsor_name":"Assistance Publique - Hôpitaux de Paris","has_results":false},{"nct_id":"NCT00055172","title":"Genetic Basis of Immunodeficiency","phase":"","overall_status":"RECRUITING","enrollment_count":100,"lead_sponsor_name":"National Heart, Lung, and Blood Institute (NHLBI)","has_results":false},{"nct_id":"NCT01529827","title":"Fludarabine Phosphate, Melphalan, and Low-Dose Total-Body Irradiation Followed by Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Hematologic Malignancies","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":94,"lead_sponsor_name":"Roswell Park Cancer Institute","has_results":true},{"nct_id":"NCT05651113","title":"The Experience of Screening for SCID","phase":"","overall_status":"RECRUITING","enrollment_count":90,"lead_sponsor_name":"King's College London","has_results":false},{"nct_id":"NCT04172181","title":"Multi-center Clinical Study of Cord Blood Stem Cell Transplantation for SCID","phase":"","overall_status":"UNKNOWN","enrollment_count":50,"lead_sponsor_name":"Children's Hospital of Fudan University","has_results":false},{"nct_id":"NCT00695279","title":"Long Term Follow Up Of Patients Who Have Received Gene Therapy Or Gene Marked Products","phase":"","overall_status":"COMPLETED","enrollment_count":41,"lead_sponsor_name":"St. Jude Children's Research Hospital","has_results":false},{"nct_id":"NCT00006335","title":"Influences on Female Adolescents' Decisions Regarding Testing for Carrier Status of XSCID","phase":"","overall_status":"COMPLETED","enrollment_count":40,"lead_sponsor_name":"National Human Genome Research Institute (NHGRI)","has_results":false},{"nct_id":"NCT01306019","title":"Lentiviral Gene Transfer for Treatment of Children Older Than Two Years of Age With X-Linked Severe Combined Immunodeficiency (XSCID)","phase":"PHASE1, PHASE2","overall_status":"RECRUITING","enrollment_count":40,"lead_sponsor_name":"National Institute of Allergy and Infectious Diseases (NIAID)","has_results":false},{"nct_id":"NCT03878069","title":"Registry Study of Revcovi Treatment in Patients With ADA-SCID","phase":"","overall_status":"COMPLETED","enrollment_count":32,"lead_sponsor_name":"Chiesi Farmaceutici S.p.A.","has_results":true},{"nct_id":"NCT04246840","title":"Study Through Imaging of Visceral Lymphoid Organs in Patients With SCID Who Have Recieved Bone Marrow Allograft","phase":"","overall_status":"COMPLETED","enrollment_count":18,"lead_sponsor_name":"Association Pour l'Aide a la Recherche en Immunologie Pediatrique","has_results":false},{"nct_id":"NCT06851767","title":"Base-Edited Hematopoietic Stem/Progenitor Cell X-Linked Severe Combined Immunodeficiency Gene Therapy","phase":"PHASE1, PHASE2","overall_status":"ENROLLING_BY_INVITATION","enrollment_count":18,"lead_sponsor_name":"National Institute of Allergy and Infectious Diseases (NIAID)","has_results":false},{"nct_id":"NCT03232203","title":"Evaluating the Effectiveness of STRIMVELIS Risk Minimization Measures (RMMs)","phase":"","overall_status":"COMPLETED","enrollment_count":16,"lead_sponsor_name":"Fondazione Telethon","has_results":false},{"nct_id":"NCT04959890","title":"Methodology Study of Retroviral Insertion Site Analysis in Strimvelis Gene Therapy","phase":"","overall_status":"UNKNOWN","enrollment_count":15,"lead_sponsor_name":"Fondazione Telethon","has_results":false},{"nct_id":"NCT05298930","title":"Feasibility Study to Assess an Adapted Physical Activity Program in Children, Adolescents and Young Adults Requiring Hematopoietic Stem Cell Transplantation","phase":"NA","overall_status":"COMPLETED","enrollment_count":15,"lead_sponsor_name":"Centre Leon Berard","has_results":false},{"nct_id":"NCT03765632","title":"Efficacy and Safety of the Cryopreserved Formulation of OTL-101 in Subjects With ADA-SCID","phase":"PHASE1, PHASE2","overall_status":"COMPLETED","enrollment_count":13,"lead_sponsor_name":"Great Ormond Street Hospital for Children NHS Foundation Trust","has_results":false},{"nct_id":"NCT03879876","title":"Safety and Efficacy Study of Human T Lymphoid Progenitor (HTLP) Injection After Partially HLA Compatible Allogeneic Hematopoietic Stem Cell Transplantation in SCID Patients","phase":"PHASE1, PHASE2","overall_status":"UNKNOWN","enrollment_count":12,"lead_sponsor_name":"Assistance Publique - Hôpitaux de Paris","has_results":false},{"nct_id":"NCT03311503","title":"Phase I/II Trial of Lentiviral Gene Transfer for SCID-X1 With Low Dose Targeted Busulfan Conditioning","phase":"PHASE1, PHASE2","overall_status":"RECRUITING","enrollment_count":12,"lead_sponsor_name":"David Williams","has_results":false},{"nct_id":"NCT04797260","title":"Phase I/II Clinical Trial Stem Cell Gene Therapy in RAG1-Deficient SCID","phase":"NA","overall_status":"RECRUITING","enrollment_count":10,"lead_sponsor_name":"Leiden University Medical Center","has_results":false},{"nct_id":"NCT02999984","title":"Efficacy and Safety of the Cryopreserved Formulation of OTL-101 in Subjects With ADA-SCID","phase":"PHASE1, PHASE2","overall_status":"COMPLETED","enrollment_count":10,"lead_sponsor_name":"University of California, Los Angeles","has_results":true},{"nct_id":"NCT03645460","title":"Gene Therapy for ADA-SCID Using an Improved Lentiviral Vector (Ivlv-ADA)","phase":"NA","overall_status":"RECRUITING","enrollment_count":10,"lead_sponsor_name":"Shenzhen Geno-Immune Medical Institute","has_results":false},{"nct_id":"NCT02127892","title":"SCID Bu/Flu/ATG Study With T Cell Depletion","phase":"PHASE1, PHASE2","overall_status":"TERMINATED","enrollment_count":9,"lead_sponsor_name":"Neena Kapoor, M.D.","has_results":true},{"nct_id":"NCT00018018","title":"Gene Transfer Therapy for Severe Combined Immunodeficieny Disease (SCID) Due to Adenosine Deaminase (ADA) Deficiency","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":8,"lead_sponsor_name":"National Human Genome Research Institute (NHGRI)","has_results":false},{"nct_id":"NCT01420627","title":"EZN-2279 in Patients With ADA-SCID","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":7,"lead_sponsor_name":"Leadiant Biosciences, Inc.","has_results":true},{"nct_id":"NCT05071222","title":"Safety and Efficacy Study of Transplantation of Autologous CD34+ Cells Transduced With the G2ARTE Lentiviral Vector Expressing the DCLRE1C cDNA in Artemis (DCLRE1C) Deficient Severe Combined Immunodeficiency Patients (ARTEGENE)","phase":"PHASE1, PHASE2","overall_status":"RECRUITING","enrollment_count":7,"lead_sponsor_name":"Assistance Publique - Hôpitaux de Paris","has_results":false},{"nct_id":"NCT03513328","title":"Conditioning Regimen for Allogeneic Hematopoietic Stem-Cell Transplantation","phase":"PHASE1, PHASE2","overall_status":"COMPLETED","enrollment_count":6,"lead_sponsor_name":"University of Florida","has_results":true},{"nct_id":"NCT00008450","title":"Total-Body Irradiation Followed By Cyclosporine and Mycophenolate Mofetil in Treating Patients With Severe Combined Immunodeficiency Undergoing Donor Bone Marrow Transplant","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":6,"lead_sponsor_name":"Fred Hutchinson Cancer Center","has_results":false},{"nct_id":"NCT03597594","title":"Haplocompatible Transplant Using TCRα/β Depletion Followed by CD45RA-Depleted Donor Lymphocyte Infusions for Severe Combined Immunodeficiency (SCID)","phase":"PHASE1, PHASE2","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":4,"lead_sponsor_name":"St. Jude Children's Research Hospital","has_results":false},{"nct_id":"NCT00028236","title":"Stem Cell Gene Therapy to Treat X-Linked Severe Combined Immunodeficiency (XSCID)","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":3,"lead_sponsor_name":"National Institute of Allergy and Infectious Diseases (NIAID)","has_results":false},{"nct_id":"NCT04140539","title":"A Clinical Study to Enable Process Validation of Commercial Grade OTL-101","phase":"PHASE2, PHASE3","overall_status":"WITHDRAWN","enrollment_count":0,"lead_sponsor_name":"University of California, Los Angeles","has_results":false},{"nct_id":"NCT06731036","title":"Expanded Access to CD34+ Selection Utilizing Miltenyi CliniMACS Prodigy® for Patients Receiving Peripheral Blood Stem Cell Transplantations and Stem Cell Boosts","phase":"","overall_status":"AVAILABLE","enrollment_count":null,"lead_sponsor_name":"University of Florida","has_results":false}],"total":31},"guidelines":[],"source":"Drug Landscape verified database"}